ERK1/2²ÎÓëIL¡ª33ÓÕµ¼µÄÐÄÔà³ÉÏËάϸ°ûÔöÖ³ºÍÏËά»¯¹ý³Ì(3)
¡¡¡¡Ñо¿·¢ÏÖIL-33¹ã·º´æÔÚÓÚ¶àÖÖ×éÖ¯ºÍϸ°ûÉÏ£¬Èç³ÉÏËάϸ°û¡¢Æ½»¬¼¡Ï¸°û¡¢ÄÚÆ¤Ï¸°ûºÍÉÏÆ¤Ï¸°û£¬ÔÚÏø´¡¢×ÔÉíÃâÒßÐÔ¼²²¡¡¢ÌÇÄò²¡¡¢Ñª¹ÜÑ×Ö¢¡¢¿¹¶¯ÂöÖàÑùÓ²»¯¡¢¿¹Ðļ¡Ï¸°û·Ê´óºÍÐļ¡ÏËά»¯µÄ¹ý³ÌÖз¢»ÓÖØÒª×÷ÓÃ[10]¡£IL-33¿ÉÌØÒìÐÔ¼¤»îST2£¬ST2»ùÒò±àÂë²úÉúÁ½ÖÖµ°°×£º¿çĤÐÎʽST2LºÍ·ÖÃÚÐÎʽsST2¡£ÔÚÉúÎï»úеѹÁ¦µÄÓÕµ¼Ï£¬ Ðļ¡Ï¸°ûºÍÐÄÔà³ÉÏËάϸ°û¾ùÄܱí´ïST2¡£ÔÚIL-33/ST2ÐźÅͨ·ÖУ¬IL-33ÓëST2L¡¢IL-1ÊÜÌ帨Öúµ°°×£¨IL-1 receptor accessory protein£¬IL-1RAcP£©×é³ÉÊÜÌ帴ºÏÎ»î»¯ÏÂÓÎÐźÅTRAF6¡¢×ª»¯Éú³¤Òò×ÓÏà¹Ø-1£¨TAK1£©£¬½ø¶ø¼¤»îp38¡¢JNK¡¢NF-kB µÈͨ··¢»ÓÉúÎïѧ×÷Óá£sST2¿É¸ºÏòµ÷½ÚIL-33/ST2ͨ·µÄ´«µ¼[4]¡£ÓÐÑо¿Ö¤Êµ£¬TRAF6 ÊÇIL-33½éµ¼p38¡¢JNK ºÍNF-kB»î»¯µÄ¹Ø¼üÐźŷÖ×Ó[5£¬11-13]¡£±¾Ñо¿·¢ÏÖ£¬IL-33ÄÜÓÕµ¼ÐÄÔà³ÉÏËάϸ°ûÃ÷ÏÔ±í´ïTRAF-6£¬±íÃ÷ÓÐIL-33/ST2ͨ·µÄ¼¤»î¡£
¡¡¡¡´Ù·ÖÁÑԻµ°°×¼¤Ã¸£¨MAPK£©ÔÚÐí¶àÐÄѪ¹Ü¼²²¡µÄ·¢²¡»úÖÆÖÐÆð×ÅÖØÒª×÷Óã¬ÈçÐļ¡·Êºñ¡¢Ðļ¡ÏËά»¯¼°ÐÄÁ¦Ë¥½ßµÈ[13£¬14]¡£MAPK°üÀ¨p38 MAPK¡¢c-Jun°±»ùÄ©¶Ë¼¤Ã¸£¨JNK£©/Ó¦¼±¼¤»îµÄµ°°×¼¤Ã¸£¨SAPK£©¼°Ï¸°ûÍâµ÷½Úµ°°×¼¤Ã¸£¨ERK1/2£©ÈýÌõͨ·£¬ÆäÖÐERK1/2ÊÇÐ£ËÀºóÐÄÊÒÖØËܵÄÖØÒªÐźÅͨ·֮һ[15£¬16]¡£ÓÐÑо¿±¨µÀ£¬È©¹Ìͪͨ¹ý¼¤»îERK1/2 ¶ø´Ì¼¤ÐÄÔà³ÉÏËάϸ°ûÔöÖ³£¬¶øÇÒÒÖÖÆERK1/2»î»¯ÄÜÒÖÖÆIL-1β ÓÕ·¢µÄ»ùÖʽðÊôµ°°×ø-9£¨MMP-9£©·ÖÃÚ[15-17]¡£ÎÒÃǵÄÑо¿½á¹û·¢ÏÖ£¬ÔÚÐÄÔà³ÉÏËάϸ°ûÖÐIL-33 /ST2 ͨ·»î»¯ºóÄܽøÒ»²½¼¤»îÏÂÓÎERK1/2ͨ·¡£ÒÑÖªα-SMAÊǼ¡³ÉÏËάϸ°ûµÄ±ê¼ÇÐÔµ°°×£¬³ÉÏËάϸ°ûÔöÖ³¡¢»î»¯ºóÆä±í´ïÉý¸ß¡£±¾Ñо¿Í¨¹ýIL- 33ÓÕµ¼½¨Á¢ÏËά»¯Ï¸°ûÄ£ÐÍ£¬ÔÚÕâÒ»¹ý³ÌÖÐα-SMA »ùÒòºÍµ°°×ˮƽÃ÷ÏÔ±í´ï£¬²¢ÇÒÕâһЧӦÄܱ»ERK1 /2ÌØÒìÐÔ×è¶Ï¼ÁPD98059Ëù×è¶Ï¡£Òò´Ë£¬IL- 33ÄÜÓÕµ¼ÐÄÔà³ÉÏËάϸ°ûÏò¼¡³ÉÏËάϸ°ûת·Ö»¯£¬ÕâÒ»¹ý³ÌÓÐIL-33/ST2-TRAF-6- ERK1/2ͨ·²ÎÓëµ÷¿Ø¡£µ±È»Ä¿Ç°¶ÔIL-33ÔÚÐļ¡ÏËά»¯ÖеÄ×÷ÓûúÖÆ»¹ÓдýÓÚ½øÒ»²½²ûÃ÷£¬ÆÚÍûÄÜΪÐļ¡ÏËά»¯ÖÎÁÆÑо¿ÌṩÐÂ˼·¡£
¡¡¡¡[²Î¿¼ÎÄÏ×]
¡¡¡¡[1] ÍõÓí´¨£¬¶¡ÑàÉú£¬Áõ÷ÁÖ£¬µÈ. ²»Í¬Òò×ÓÖÂÐļ¡ÏËά»¯·Ö×Óѧ»úÖÆ[J]. ҽѧ×ÛÊö£¬2012£¬18£¨17£©£º2736-2740.
¡¡¡¡[2] Marchant DJ£¬Boyd JH£¬Lin DC£¬et al. Inflammation in myocardial[J]. Circ Res£¬2012£¬110£¨1£©£º126-144.
¡¡¡¡[3] ÕÅÏþ¸è£¬ÌÕСÁᣬÕÅÏÍÈñ£¬µÈ. PLGF ²ÎÓëAng¢òÓÕµ¼µÄÐÄÔà³ÉÏËάϸ°û¼¤»î[J]. Öйú²¡ÀíÉúÀíÔÓÖ¾£¬2013£¬29£¨4£©£º603-608.
¡¡¡¡[4] Zhu J£¬Carver W. Effects of interleukin-33 on cardiac fibroblast gene expression and activity[J]. Cytokine£¬2012£¬ 58£¨3£©£º368-379.
¡¡¡¡[5] Miller AM£¬ Liew FY. The IL-33/ST2 pathway-A new therapeutic target in cardiovascular disease[J]. Pharmacol Ther£¬2011£¬131£¨2£©£º179-186.
¡¡¡¡[6] Garg A£¬Akoum N. Atrial fibrillation and heart failure£ºBeyond the heart rate[J]. Curr Opin Cardiol£¬2013£¬28£¨3£©£º332-336.
¡¡¡¡[7] ÀîÃÈ£¬ÂÀÊ˳¬£¬ÎâÃÀ·¼£¬µÈ. ²»Í¬ÔÒòÓÕµ¼µÄÐļ¡ÏËά»¯¶¯ÎïÄ£Ð͵Ľ¨Á¢[J]. ҽѧÑо¿Éúѧ±¨£¬2014£¬27£¨3£©£º330-334.
¡¡¡¡[8] Xu X£¬Ding F£¬Pang J£¬et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat[J]. Am J Physiol Heart Circ Physiol£¬2012£¬ 303£¨6£©£º703-711.
¡¡¡¡[9] Carnevale D£¬Lembo G. Placental growth factor and cardiac inflammation[J]. Trends Cardiovasc Med£¬2012£¬22£¨8£©£º209-212.
¡¡¡¡[10] Rui T£¬ Zhang J£¬ Xu X£¬ et al. Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus[J]. Cardiovasc Res£¬2012£¬ 94£¨2£©£º370-378.
¡¡¡¡[11] Rui T£¬ Tang Q. IL-33 attenuates anoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibition of PKCβ/JNK pathway[J]. PLoS One£¬2013£¬8£¨2£©£º e56089.
¡¡¡¡[12] ÁõÀö»ª£¬·¿²Êϼ£¬µËÓÀ¹ó£¬µÈ. JNKÐźÅͨ·½éµ¼¸ßÌÇÓÕµ¼µÄ´óÊóÐÉÏËάϸ°û[J]. »ù´¡Ò½Ñ§ÓëÁÙ´²£¬2013£¬ 33£¨2£©£º199-204.
¡¡¡¡[13] Fu X£¬Koller S£¬Abd Alla J£¬et al. Inhibition of G-protein-coupled receptor kinase 2£¨GRK2£© triggers the growth-promoting mitogen-activated protein kinase£¨MAPK£© pathway[J]. J Biol Chem£¬2013£¬288£¨11£©£º7738-7755.
¡¡¡¡[14] лÓÀ½ø£¬¸Ç³ÔÁ. Ѫ¹Ü½ôÕÅËØ¢òÖÂÐļ¡ÏËά»¯¼°ÆäÐźÅתµ¼»úÖÆÑо¿½øÕ¹[J]. ½â·Å¾üҽѧԺѧ±¨£¬2014£¬35£¨6£©£º630-633.
¡¡¡¡[15] Zhang H£¬Wang ZW£¬Wu HB£¬et al. Transforming growth factor-β1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-κB pathways[J]. Mol Cell Biochem£¬2013£¬375£¨1-2£©£º11-21.
¡¡¡¡[16] Jung SY£¬Choi SH£¬Yoo SY£¬et al. Modulation of human cardiac progenitors via hypoxia-erk circuit improves their functional bioactivities[J]. Biomol Ther £¨ Seoul£©£¬2013£¬ 21£¨3£©£º196-203.
¡¡¡¡[17] ÑîÈØ£¬³£ÁÁ£¬Áõ½ðÃ÷. ÂÞ¸ñÁÐͪ¶Ô¸ßÌǴ̼¤ÏÂÐÂÉú´óÊóÐÄÔà³ÉÏËάϸ°û¢ñÐÍǰ½ºÔ±í´ïµÄµ÷½Ú[J]. ÖйúÒ½Ò©µ¼±¨£¬2013£¬10£¨21£©£º 9-12.
£¨www.fabiaoba.com£©£¬ÊÇÒ»¸öרÃÅ´ÓÊÂÆÚ¿¯ÍƹãÆÚ¿¯·¢±í¡¢Í¶¸å¸¨µ¼¡¢·¢±íÆÚ¿¯µÄÍøÕ¾¡£
¡¡¡¡±¾Õ¾ÌṩÈçºÎͶ¸å¸¨µ¼¡¢·¢±íÆÚ¿¯£¬Ñ°ÇóÂÛÎÄ¿¯µÇºÏ×÷£¬¿ìËÙͶ¸å¸¨µ¼£¬Í¶¸å¸¨µ¼¸ñʽָµ¼µÈ½â¾ö·½°¸£ºÊ¡¼¶ÂÛÎÄ¿¯µÇ/¹ú¼Ò¼¶ÂÛÎÄ¿¯µÇ/
CSSCIºËÐÄ/ҽѧͶ¸å¸¨µ¼/Ö°³ÆÍ¶¸å¸¨µ¼¡£
Ͷ¸åÓÊÏ䣺fabiaoba365@126.com
¡¡ÔÚÏß×Éѯ£º
275774677¡¢
1003180928
¡¡ÔÚÏß×Éѯ£º
610071587¡¢
1003160816
¡¡ÁªÏµµç»°£º13775259981